Pharmaceutical

Sanofi reports Q4 2024 increase in net income to $916m

Sanofi has announced an increase in net income from continuing operations for the fourth quarter (Q4) of 2024, reaching €880m ($833m).

Feb 1, 2025 - 06:00
Sanofi reports Q4 2024 increase in net income to $916m
Sanofi has announced an increase in net income from continuing operations for the fourth quarter (Q4) of 2024, reaching €880m ($833m).
Read the original article

Tags:

Previous Article

All change in Germany – confidential pricing in, IRP out

Next Article

Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Menarini signs agreement for Astellas’s rheumatoid arthritis therapy

Menarini signs agreement for Astellas’s rheumatoid arth...

Sep 13, 2023

Rystiggo receives FDA approval, strengthening UCB’s myasthenia gravis portfolio

Rystiggo receives FDA approval, strengthening UCB’s mya...

Jun 27, 2023

STAT+: Novartis to buy German biotech MorphoSys for $2.9 billion

STAT+: Novartis to buy German biotech MorphoSys for $2....

Feb 5, 2024